These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The influence of vascular risk factors and white matter hyperintensities on the degree of motor impairment in Parkinson's disease]. Derejko M; Sławek J; Wieczorek D; Dubaniewicz M; Lass P Neurol Neurochir Pol; 2006; 40(4):276-83. PubMed ID: 16967348 [TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease. Burciu RG; Ofori E; Shukla P; Planetta PJ; Snyder AF; Li H; Hass CJ; Okun MS; McFarland NR; Vaillancourt DE Mov Disord; 2015 Aug; 30(9):1248-58. PubMed ID: 26148135 [TBL] [Abstract][Full Text] [Related]
6. Track density imaging in progressive supranuclear palsy: A pilot study. Nigro S; Bianco MG; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Augimeri A; Quattrone A Hum Brain Mapp; 2019 Apr; 40(6):1729-1737. PubMed ID: 30474903 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy. Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation. Murthy M; Fodder K; Miki Y; Rambarack N; De Pablo Fernandez E; Pihlstrøm L; Mill J; Warner TT; Lashley T; Bettencourt C Acta Neuropathol; 2024 Jul; 148(1):4. PubMed ID: 38995454 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease. Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973 [TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy and idiopathic Parkinson's disease are associated with local reduction of in vivo brain viscoelasticity. Lipp A; Skowronek C; Fehlner A; Streitberger KJ; Braun J; Sack I Eur Radiol; 2018 Aug; 28(8):3347-3354. PubMed ID: 29460073 [TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease. Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924 [TBL] [Abstract][Full Text] [Related]
15. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors. Sławek J; Roszmann A; Robowski P; Dubaniewicz M; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Kurzawski M; Bandurski T; Białecka M Neurodegener Dis; 2013; 12(1):1-12. PubMed ID: 22831964 [TBL] [Abstract][Full Text] [Related]
16. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease. Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492 [TBL] [Abstract][Full Text] [Related]
17. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Price S; Paviour D; Scahill R; Stevens J; Rossor M; Lees A; Fox N Neuroimage; 2004 Oct; 23(2):663-9. PubMed ID: 15488416 [TBL] [Abstract][Full Text] [Related]